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Abstract
Background: This study aimed to investigate the association between 25-hydroxyvitamin D (25(OH)D) and depres‑
sion symptoms among adolescents in Kuwait, a country with a high prevalence of vitamin D deficiency.
Methods: A school based cross-sectional study was conducted on randomly selected 704 adolescents in mid‑
dle schools. Data on depression symptoms were collected using the Children’s Depression Inventory (CDI). Data on
covariates were collected from the parents by self-administered questionnaire and from adolescents by face-to-face
interview. Blood samples were analyzed in an accredited laboratory; and 25(OH)D was measured using liquid chroma‑
tography-tandem mass spectrometry.
Results: Of 704 adolescents, 94 (13.35%; 95%CI:10.35–17.06%) had depression symptom (a score of 19 or more on
the CDI). There was no significant difference in the median CDI score between different vitamin D status (p = 0.366).
There was also no significant correlation between serum 25(OH)D concentration and CDI score (Spearman’s rank cor‑
relation = 0.01; p = 0.825).There was no significant association between 25(OH)D and depression symptoms whether
25(OH)D was fitted as a continuous variable (crude odds ratio (OR) 0 .99 [95%CI: 0.98, 1.01], p = 0.458 and adjusted
OR 1.01 [95%CI: 0.99, 1.02], p = 0.233), categorical variable as per acceptable cut-of points (crude analysis p = 0.376
and adjusted analysis p = 0.736), or categorical variable as quartiles (crude analysis p = 0.760 and adjusted analysis
p = 0.549).
Conclusion: Vitamin D status does not seem to be associated with depression symptoms among adolescents in our
setting. Nevertheless, it is important to have sufficient vitamin D levels during adolescence for several other health
benefits.
Keywords: Depression, Vitamin D, Adolescents, Kuwait
Introduction
The global burden of disease study demonstrated that
depression is a major public health problem and is the
leading cause of disability worldwide [1]. Depression
affects more than 280 million individuals causing great
economic burden not only on the affected individuals
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but also, on their families, communities, employers,
and healthcare services [2]. Furthermore, interventions
that aim to prevent or improve the outcome of depression have limited success [3] highlighting the need to
expand the knowledge on potential risk factors which
might influence the risk and the pathogenesis of depression symptoms. The literature suggests that life style factors such as diet [4, 5] and physical activity are related to
depression symptoms [6, 7]. Recently, the link between
the deficiency in specific nutritional elements such as
vitamin D and depression has come under intense debate.
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Vitamin D has a well-established role in calcium and
phosphorus homeostasis, bone health and various cellular and neuromuscular functions [8]. But recent literature linked low vitamin D levels to several adverse
health outcome such as cancer [9], type 2 diabetes
[10], multiple sclerosis [11], autism [12], and asthma
[13] as well as all-causes mortality [14]. Recently, low
vitamin D levels have been linked to the risk [15] and
severity [16] of COVID-19. Vitamin D is derived mainly
through exposure to sunlight and the link between
depression and the lack of sunlight exposure was first
noted two thousand years ago [17]. There are several
plausible mechanisms in which vitamin D may affect
mental health. Vitamin D can cross the blood–brain
barrier [18], hence activate the vitamin D receptors
(VDR) which are expressed in brain cells along with
vitamin D metabolizing enzymes [19–21]. Also, vitamin D is involved in signaling cascades and neurobiological pathways [20] which may affect mental health.
The active metabolite of vitamin D is thought to modulate the differentiation and maturation of dopaminergic
neurons [22] and to affect brain serotonin concentrations [20, 23]. Finally, it is postulated that depression
is associated with increased inflammatory markers [24], while vitamin D has been shown to downregulate inflammatory markers that have been linked
to stress and depression [25]. Despite the evidence
that vitamin D may play an important function in the
human brain, the exact biological mechanisms linking
vitamin D to depression are still not fully understood
and remain controversial.
Several observational studies have suggested an association between vitamin D deficiency and major depressive
disorders in adults (reviewed by Anglin et al. [26] and
Ju et al. [27]). The observational nature of these studies
means that it is difficult to ascertain the temporal relationship between vitamin D and depression as some individuals with depression may avoid outdoor activities and
have poor diet, resulting in reduced sunlight exposure
and consequently reduced endogenous vitamin D synthesis, as well as reduced dietary vitamin D intake [28, 29].
Trials on vitamin D supplementation and depression in
adults showed controversial results (reviewed by Cheng
et al. [30], Gowda et al. [31], Li et al. [32], Spedding et al.
[33], Shaffer et al. [34], and Vellekkatt et al. [35]). In children and adolescents, a recent literature review of observational and interventional studies concluded that there
might be a positive influence of vitamin D on mental
health in children [36]. The reviewed studies were controversial and heterogeneous which preclude making a
robust conclusion and the authors highlighted the need
for more studies to facilitate comparisons and deepen the
observations.

Page 2 of 11

We have previously demonstrated that 81% of schoolchildren in Kuwait were vitamin D deficient [37]. In this
study, we aimed to estimate the prevalence of depression symptoms and investigate the association between
Serum 25-hydroxyvitamin D (25(OH)D) and depression
symptoms among schoolchildren in Kuwait, a country
with plenty of sunshine.

Methods
Participants

The study was conducted within a project that aimed to
assess vitamin D status in middle schoolchildren (11–
16 years) in Kuwait. The details of the project have been
described previously [37, 38]. In this project, a nationally representative sample of middle schoolchildren
was selected using probability proportional to size sampling method. Trained nurses drew blood samples while
trained data collectors gathered data on factors related
to lifestyle such as physical activity, sleeping habits, and
smoking through face-to-face interviews. Data on sociodemographic factors were collected from the parents
of sampled schoolchildren through a self-administered
questionnaire.
Another team of researchers at a later time was formulated to interview the schoolchildren and collect data on
depression symptoms and its related factors. This was
conducted on a subgroup of students (N = 704). Parents
provided written informed consent while schoolchildren
provided verbal assents before data collection. Both the
Ethics Committee at the Health Sciences Centre, Kuwait
University (No: DR/EC/2338) and the Ethics Committee at The Ministry of Health in Kuwait (No: 2015/248)
approved the study.
Collection of blood samples and laboratory methods

Serum 25-hydroxyvitamin D (25(OH)D) level was measured using liquid chromatography-tandem mass spectrometry (LC–MS/MS), which is the gold standard
method to assess vitamin D status [39, 40]. Other biological measurements including complete blood count,
Parathyroid Hormone (PTH), vitamin B12, Iron, ferritin,
transferrin and transferrin saturation were all measured
in an accredited clinical biochemistry laboratory in a
teaching hospital under strict quality control. Details of
these measurements have been described before [37, 38].
Data collection on depression symptoms

Data on depression symptoms were collected using
the Children’s Depression Inventory (CDI) [41], which
has been previously translated and adopted in our setting [42]. The CDI is a 27-item self-rated symptom scale
instrument, which was originally developed based on
Beck’s Depression Inventory (BDI) [43], to screen for
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depression symptoms in children and adolescents aged
7–17 years. The CDI scores symptoms of depression
on five subscales that include negative mood, interpersonal problems, ineffectiveness, anhedonia and negative self-esteem with 27 items scored on a 3-point scale
(0: absence of the symptom, 1: moderate symptom, 2:
severe symptom). The total CDI score is calculated by
summing all items, which ranges between 0 (no depression symptom) and 54 (all depression symptoms exist).
Several cut-off scores have been recommended such as
“ > 13”, “ > 16” and “ ≥ 19” to indicate elevated depression
symptoms in adolescents [44]. It has been suggested that
a score of ≥ 19 is an appropriate cut-off point for population-based assessment, with 95% and 96% sensitivity and
specificity respectively [45, 46]. Also, several studies have
adopted this cut-off score to investigate depression symptoms in community-based studies [47–50].
Data collection on covariates

Data were collected on socio-economic and lifestylerelated factors using self-administered questionnaire that
were sent to the parents. Data on behavioral factors such
as physical activity, sedentary lifestyle, sleeping hours
during weekdays and weekends were collected by faceto-face interviews with schoolchildren by trained team of
data collectors. Data on physical activity were collected
by a series of questions that were validated among high
school students and showed strong correlation with data
objectively measured by accelerometers. The total time
spent on physical activity per week was calculated. Similarly, data on sedentary lifestyle were collected using a
group of questions about the time spent on watching TV,
playing video games, using the internet/computer and
setting to read/do homework during weekdays and weekends. Standing height and body weight of the schoolchildren were measured using digital weight and height scale
(Detecto®) in a standardized manner by trained data
collectors.
Statistical analysis

Using Epidata Entry software, data were double entered
into specifically designed database. Then data were transferred to STATA (StataCorp. 2011. Release 14) for data
analysis. We used Spearman’s rank correlation to investigate the linear association between CDI score and
25(OH)D level. Vitamin D status was defined according
to the Endocrine Society [51] and the Society for Adolescent Health and Medicine [52] as deficiency < 50 nmol/L;
insufficiency 50–75 nmol/L; sufficiency ≥ 75 nmol/L.
Kruskal–Wallis test was used to investigate the difference
in CDI score across different vitamin D status (severe
deficiency, deficiency, insufficiency, sufficiency).
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The association between 25(OH)D and depression
symptoms (CDI score ≥ 19) was assessed using unconditional logistic regression with adjustment for potential
confounders. Separate analyses were performed with
25(OH)D fitted as a continuous variable and as a categorical variable. We categorized 25(OH)D using acceptable
cutoff points [51] or quartiles. First, crude odds ratios
were calculated, then statistically significant variables at
20% level of significant were introduced sequentially to
the model while noting the impact of this on the association between 25(OH)D and depression symptoms. There
was no difference in conclusion between this analysis
and the analysis that was guided by the theory based on
the studies that have investigated factors associated with
depression symptoms among adolescents and children
[53, 54]. As a sensitivity analysis, we used stepwise logistic regression to explore if the conclusion on the association between 25(OH)D and depression symptoms would
be different with stepwise variables selection. Furthermore, we used simultaneous quantile regression to assess
the association between 25(OH)D (as a continuous and
categorical variable) and CDI score as a quantitative outcome using bootstrap to estimate the standard error with
500 replications. Throughout the analysis, all tests were
two tailed and factors that showed p < 0.05 were deemed
to be statistically significant.

Results
The analysis included 704 schoolchildren of whom 353
(50.14%) were males. The mean (standard deviation: SD)
age was 12.25 (0.80) years. Of 704 schoolchildren, 94
(13.35%; 95%CI:10.35–17.06%) had depression symptoms
(a score of 19 or more on the CDI). Figure 1 shows the
distribution of CDI score in different vitamin D status.
There was no significant difference in the median CDI
score across different vitamin D status (p = 0.366) or different serum 25(OH)D quartiles (p = 0.540). There was
also no significant correlation between serum 25(OH)
D concentration and CDI score (Spearman’s rank correlation = 0.01; p = 0.825) or between PTH and CDI score
(Spearman’s rank correlation = 0.06; p = 0.145).
Table 1 shows the association between sociodemographic factors and depression symptoms (CDI
score ≥ 19) in univariable analysis. Only maternal education showed inverse significant association with depression symptoms (p = 0.021). None of the lifestyle factors
including the time spent on physical activity (p = 0.461),
time spent on sedentary activities (p = 0.714) or body
mass index (BMI) categories (p = 0.185) was significantly
associated with depression symptoms in univariable analysis (Table 2). However, hours of sleep during weekdays
(p = 0.063) and weekends (p = 0.079), and the number of
times walking to/from school (p = 0.066) were borderline
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significantly associated with depression symptoms.
Except for PTH, calcium, vitamin B12, anemia, iron, ferritin and folate were all not significantly associated with
depression symptoms (Table 3). It is worth noting that
the association between PTH and depression symptoms
was significant when it was fitted as a continuous variable, but no association was found when PTH was categorized into quartile, tertiles or by the normal value range
provided by our laboratory.
Table 4 shows the association between 25(OH)D and
depression symptoms before and after adjusting for
potential confounders. There was no significant association between 25(OH)D and depression symptoms
whether 25(OH)D was fitted as a continuous variable
(crude analysis p = 0.458 and adjusted analysis p = 0.233),
categorized by acceptable cut-of points (crude analysis p = 0.376 and adjusted analysis p = 0.736), or when
categorized as quartiles (crude analysis p = 0.760 and
adjusted analysis p = 0.549). To confirm these findings,
forward and backward stepwise logistic regression were
used, and 25(OH)D was not selected in any model. Similarly, quantile regression showed no association between
25(OH)D and CDI score in any model (data are not
shown). Finally, we investigated the interaction between
25(OH)D and BMI categories as some literature suggested [55]. Only the interaction between 25(OH)D
quartiles and BMI categories was statistically significant
(p = 0.021).

Discussion
This study aimed to estimate the prevalence of depression symptoms among schoolchildren and investigate the
association between 25(OH)D and depression symptoms.
The prevalence of depression symptoms in schoolchildren was 13.35% and no association was found between
25(OH)D and the CDI depression score. Compared to
similar studies that used the CDI and similar cut-off point
score, the prevalence of depression symptoms in our setting seems to be lower than that reported from Uganda
or Iran (21% and 25.6% respectively) [47, 56], higher than
that reported from Cyprus (10.25%)[50], and similar to
that reported from Egypt (13.3%) [57].
Our findings suggest that neither vitamin D status nor
levels is associated with depression symptoms in adolescents in Middle Eastern settings. Recently, several observational studies have attempted to investigate the link
between low vitamin D levels and depression or mental
health problems in children and adolescents [58–71]
(recently reviewed by Głąbska et al. [36]). Although the
review of observational studies supported the notion
that vitamin D deficiency is linked to depression or poor
mental health, the studies have significant heterogeneity, which precludes meaningful summary of these studies. This included different study populations (healthy
children or children with disease conditions such as
renal failure, bipolar disorder, or obsessive–compulsive
disorder), different methods of measurement of 25(OH)
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Table 1 Association between depression symptoms (CDI ≥ 19 score) and socio-demographic factors in adolescents using univariable
analysis (N = 704)
Characteristics

Total

Prevalence of depression
symptoms

n*

(%)

Odds ratio [95% CI]

p

Gender
Male

353

39

(11.05)

Female

351

55

(15.67)

[Ref.]
1.50

0.071

[0.96–2.32]

Age (year)
< 12

300

46

(15.33)

12-

276

33

(11.96)

0.75

[Ref.]
[0.46–1.21]

≥ 13

128

15

(11.72)

0.73

[0.39–1.37]

Kuwaiti

522

73

(13.98)

Non-Kuwait

182

21

(11.54)

Capital

117

16

(13.68)

Hawally

135

16

(11.85)

0.85

[0.40–1.78]

Farawanya

85

12

(14.12)

1.04

[0.46–2.32]

Jahra

69

8

(11.59)

0.83

[0 .33–2.05]

Mubarak al-Kabeer

81

13

(16.05)

1.21

[0.54–2.66]

Ahmadi

216

29

(13.43)

0.98

[0.51–1.89]

0.411

Nationality
[Ref.]
0.80

0.403

[0.48–1.35]

School’s Governorate
[Ref.]

0.962

Father’s Education
Primary/Intermediate/no formal education

95

19

(20.00)

Secondary (high school)

167

21

(12.57)

0.57

[Ref.]
[0.29–1.14]

Diploma

145

19

(13.10)

0.60

[0.30–1.21]

University and above

283

33

(11.66)

0.53

[0.28–0.98]

0.219

Mother’s Education
Primary/Intermediate/no formal education

68

12

(17.65)

Secondary (high school)

147

26

(17.69)

1.00

[Ref.]
[0.47–2.13]

Diploma

157

25

(15.92)

0.88

[0.41–1.88]

University and above

323

29

(8.98)

0.46

[0.22–0.96]

0.021

Father’s Income (Kuwaiti dinars)
< 500

49

3

(6.12)

500 to 1000

161

24

(14.91)

2.69

[Ref.]
[0.77–9.34]

1001 to 1500

208

34

(16.35)

3.00

[0.88–10.19]

1501 to 2000

105

10

(9.52)

1.61

[0.42–6.15]

More than 2000

95

11

(11.58)

2.01

[0.53–7.56]

Do not wish to tell

65

8

(12.31)

2.15

[0.54–8.58]

Housewife

220

32

(14.55)

Paid employment

362

47

(12.98)

0.88

[0 .54–1.42]

Other

110

14

(12.73)

0.86

[0.44–1.68]

Lives with the father and the mother

622

79

(12.70)

Lives with the mother without the father

60

10

(16.67)

1.37

[0.67–2.82]

Lives with the father without the mother

19

4

(21.05)

1.83

[0.59–5.66]

Lives with other relatives

3

1

(33.33)

3.44

[0.31–38.34]

Rented apartment

275

41

(14.91)

Rented house

74

6

(8.11)

0.320

Mother employment
[Ref.]

0.842

Living arrangements
[Ref.]

0.238

Type of housing
[Ref.]
0.50

[0.20–1.24]

0.233
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Table 1 (continued)
Characteristics

Total

Prevalence of depression
symptoms
n*

(%)

Odds ratio [95% CI]

Owned apartment

39

8

(20.51)

1.47

[0.63–3.43]

Owned house

306

38

(12.42)

0.81

[0.50–1.30]

p

Total number of siblings
≤ two

177

25

(14.12)

Three-four

274

42

(15.33)

1.10

[Ref.]
[0.64–1.88]

Five or more

242

24

(9.92)

0.67

[0.37–1.22]

First

192

21

(10.94)

Second

147

27

(18.37)

1.83

[0.99–3.39]

Third or above

351

45

(12.82)

1.20

[0.69–2.08]

No

462

58

(12.55)

Yes

241

36

(14.94)

0.173

Childbirth order
[Ref.]

0.122

Passive smoking at home
[Ref.]
1.22

0.378

[0.78–1.92]

p-value was generated by Chi-square test of independence or Fisher’s Exact. * Some values are missing, and the total may not add up to 704 for some covariates

D level, and different measures of the outcome (e.g.
Strengths and Difficulties Questionnaire, Beck Depression Inventory, Buss-Perry Aggression Questionnaire,
Young Mania Rating Scale, Children’s Depression Rating
Scale, and Mood and Feelings Questionnaire). Interventional studies that investigated the impact of vitamin D
supplementation on mental health in children and adolescents [72–74] (recently reviewed by Głąbska et al. [36])
showed that vitamin D supplementation maybe beneficial for mental health. However, similar to the observational studies, there was a significant heterogeneity in
these studies including study population (e.g. children
with sickle cell disease or autism spectrum disorder),
dosing regimens, and the outcome measurements (e.g.
Depression Scale for Children, Child Behavior Checklist, Activity of Daily Living, Screen for Child Anxiety
Related Emotional Disorders, Children’s Quality of Life
Questionnaire, and Yale-Brown Obsessive Compulsive
Scale and Children’s Depression Inventory). The review
highlighted the need for more studies to facilitate comparisons and deepen the observations [36]. A recently
reported randomized controlled trial (not included in the
previous review) on children and adolescents, who were
both vitamin D deficient and at least mildly depressed at
baseline, showed that vitamin D supplementation has no
effect on self-reported depression symptoms although a
significant decrease of parent-reported depression symptoms was found [75].
In our study, the lack of association between 25(OH)
D and depression symptoms may genuinely reflect the
absence of the relationship between vitamin D level
and depression symptoms as Mendelian randomization

studies did not indicate a causal relationship between
25(OH)D concentrations and depression [76, 77]. However, it could be due to the fact that the majority (80%)
of the study participants were vitamin D deficient.
The other possible reason is that children with severe
depression symptoms might be absent from school.
This is plausible because it is postulated that vitamin D
is beneficial only among those with clinically significant
depression symptoms, but not in healthy participants
[78] and that the presumed antidepressant effects of
vitamin D may be particularly apparent at more severe
stages of depression [61, 75]. Furthermore, we used the
CDI, which has been validated previously in our setting. In our data, the reliability of the entire CDI scale
was high (Cronbach α 0.839 [95%CI: 0.821, 0.855] and
McDonald ω 0.829 [95%CI: 0.811, 0.847]. We also found
that the CDI score to be related to students’ academic
performance (Fig. 2), which increased our confidence
in this psychometric measurement. However, it is not
clear if our findings would remain the same if we used
another psychometric measurement scale. It is difficult
to compare our findings to the previous studies that
investigated this issue using the CDI among children
and adolescents. One of these studies included children with Cystic fibrosis [58] and found an association
between vitamin D and depression symptoms while
another study used the CDI as a measure of the outcome and found male (but not female) adolescents with
major depressive disorder to have significantly lower
bone mineral density as compared to healthy controls
after adjusting for body mass and maturity [69]. In
another study, authors used the CDI as a measure of
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Table 2 Association between depression symptoms (CDI ≥ 19 score) and lifestyle factors, physical activity, body Mass Index using
univariable analysis (N = 704)
Characteristics

Total

Prevalence of depression
symptoms

n*

(%)

Odds Ratio [95% CI]

p

Times per week consumed breakfast not prepared at home
Zero

320

42

(13.13)

One-two times

284

37

(13.03)

[Ref.]
0.99

0.500

[0.62–1.59)

Three-four

51

5

(9.8)

0.72

[0.27–1.91]

Five or more

33

7

(21.21)

1.78

[0.73–4.36]

1.12

[0.66–1.88]

Times per week consumed lunch not prepared at home
Zero

185

23

(12.43)

One-two times

409

56

(13.69)

[Ref.]

Three-four

59

7

(11.86)

0.95

[0.38–2.33]

Five or more

30

4

(13.33)

1.08

[0.35–3.39]

1.20

[0.57–2.54]

0.965

Times per week consumed dinner not prepared at home
Zero

81

9

(11.11)

One-two times

436

57

(13.07)

[Ref.]

Three-four

128

15

(11.72)

1.06

[0.44–2.55]

Five or more

35

6

(17.14)

1.65

[0.54–5.07]

1.21

[0.64–2.27]

0.810

Times per week child has breakfast before going to school
Every day/Five days a week

290

42

(14.48)

Three-four days a week

94

16

(17.02)

[Ref.]

One-two days a week

118

13

(11.02)

0 .73

[0.38–1.42]

Never

193

22

(11.40)

0.76

[0.44–1.32]

0.457

Hours of sleep during weekdays
< 7.5 h (lower tertile)

205

37

(18.05)

7.5 h to < 9 h (middle tertile)

251

29

(11.55)

0.59

[0.35 -1.00]

[Ref.]

9 h or more (higher tertile)

248

28

(11.29)

0.58

[0.34–0.98]

0.063

Hours of sleep during weekend
< 9 h (lower tertile)

149

24

(16.11)

9 h to < 11 h (middle tertile)

315

32

(10.16)

0.59

[0.33 -1.04]

[Ref.]

11 or more (middle tertile)

239

38

(15.90)

0.98

[0.56–1.72]

0.079

Walking to school per week (going and coming equal 2 times)
None

562

80

(14.23)

1 to 8 times

97

6

(6.19)

0.40

[0.17 -0.94]

[Ref.]

Every day

45

8

(17.78)

1.30

[0.58–2.90]

Low (lower tertile)

224

33

(14.73)

Medium (middle tertile)

234

26

(11.11)

0.72

[0.42–1.25]

High (higher tertile)

246

35

(14.23)

0.96

[0.57–1.60]

0.066

Time spent on physical activity per week
[Ref.]

0.461

Time spent on watching TV, using internet/computer, plying video games and reading or doing homework
Low (lower tertile)

224

27

(12.05)

Medium (middle tertile)

241

32

(13.28)

1.12

[0.64–1.93]

[Ref.]

High (higher tertile)

239

35

(14.64)

1.25

[0.73–2.14]

Normal weight

303

40

(13.20)

Overweight

154

14

(9.09)

0.66

[0.34–1.25]

0.714

Body Mass Index categories
[Ref.]

Obese

235

39

(16.60)

1.31

[0.81–2.11]

Under weight

12

1

(8.33)

0.60

[0.08–4.76]

0.185

CDI: Children’s Depression Inventory. p-value was generated by Chi-square test of independence. * Some values are missing, and the total may not add up to 704 for
some covariates
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Table 3 Association between depression symptoms (CDI ≥ 19 score) and parathyroid hormone, calcium, vitamin B
 12, anemia, ferritin
and folate using univariable analysis (N = 704)
Characteristics

Total

Prevalence of depression
symptoms

Odds Ratio [95% CI]

p

1.04

(1.01- 1.09)

0.023

[Ref.]

0.213

n

(%)

703

–

–

686

90

(13.12)

17

4

(23.53)

589

76

(12.90)

24

3

(12.5)

No

654

85

(13.00)

Yes

49

8

(16.33)

1.31

[0.59- 2.88]

Iron

703

–

–

0.98

[0.94–1.02]

0.301

Normal ≥ 15 ng per mL

508

69

(13.58)

[Ref.]

0.790

Low < 15 ng per mL

195

25

(12.82)

0.93

[0.57—1.53]

Folate

704

–

–

1.00

[1.00–1.00]

Parathyroid Hormone (nmol/L)
Calcium
≥ 2.1 (mmol/L)
< 2.1 (mmol/L)

2.04

[0.65–6.39]

Vitamin B12
≥ 148 (pmol/L) sufficient
< 148 (pmol/L) deficient

[Ref.]
0.96

0.954

[0.28–3.31]

Anemia as defined by WHO [82]
[Ref.]

0.507

Ferritin

0.128

WHO: World Health Organization. p-value was generated by Chi-square test of independence, Fisher’s exact test or Wald test as appropriate. * Some values are
missing, and the total may not add up to 704 for some covariates

Table 4 Association between plasma 25-hydroxyvitamin D and depression symptoms (CDI ≥ 19 score) before and after adjusting for
potential confounders
Vitamin D

Prevalence of depression
symptoms n (%)

Crude odds ratio [95% CI]

Adjusted a
odds ratio
[95% CI]

25 (OH) D levels nmol/L

–

0.99 [0.98, 1.01]

1.01 [0.99, 1.02]

0.458

0.233

p-value
Q1 (25 (OH) D < 21 nmol/L) (n = 173)

27 (15.61)

[Reference]

[Reference]

Q2 (25 (OH) D ≥ 21 to < 30.35 nmol/L) (n = 179)

24 (13.41)

0.84 [0.46, 1.52]

1.07 [0.54,2.13]

22 (12.27)

0.78 [0.42, 1.43]

1.27 [0.60, 2.70]

Q4 (25 (OH) D ≥ 45 nmol/L) (n = 177)

21 (11.86)

0.73 [0.39, 1.34]

1.75 [0.77, 3.99]

0.760

0.549

Severe deficiency (25 (OH) D < 25 nmol/L) (n = 250)

Insufficiency (25 (OH) D ≥ 50 to < 75 nmol/L) (n = 110)

Q3 (25 (OH) D ≥ 30.35 to < 45 nmol/L) (n = 175)
p-value

39 (15.60)

[Reference]

[Reference]

Deficiency (25 (OH) D ≥ 25 to < 50 nmol/L) (n = 318)

41 (12.89)

0.80 [0.50, 1.28]

1.15 [0.65, 2.06]

10 (9.09)

0.54 [0.26, 1.13]

1.12 [0.47, 2.71]

Sufficiency (25 (OH) D ≥ 75 nmol/L) (n = 26)

4 (15.38)

0.98 [0.32, 3.01]

2.13 [0.59, 7.67]

0.376

0.736

p-value

Q1-Q4: quartile one to quartile four; 25 (OH) D: 25-Hydroxyvitamin D; a adjusted for all variables with p < 0.2 including gender, mother education, number of siblings,
sleep hours during weekdays, sleep hours during weekend, number of times walking to from school, Body Mass Index categories, Parathyroid hormone and folate.
p-value was generated by likelihood-ratio test

the outcome and compared 89 depressed adolescents
with 43 controls and found an association between
vitamin D level and depression [79]. Finally, the lack of
association between 25(OH)D and depression symptoms in our study could be attributed to different VDR
genes in our setting or the complex interaction between

vitamin D and both the serotonin transporter promotor gene polymorphism and childhood adversity experience [80].
There are several strengths in this study including
measuring 25(OH)D using a gold standard method
and collecting data from a large sample. The rigorous
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Fig. 2 Association between depression symptoms (Children’s Depression Inventory score ≥ 19) and the students’ academic performance

statistical modeling of 25(OH)D as a continuous or
a categorical variable (quartiles or established cut-of
points) and using quantile regression to model the CDI
score as a continuous, rather than a binary outcome
undoubtedly made our conclusion strong and robust.
However, we did not collect data on the history of
depression in the parents or the siblings, and exposure
to early childhood adversity experience (such as abuse,
neglect, the loss of a loved one in early life), which are
potential risk factors for depression [81]. Also, like
other epidemiological studies, we assessed depression
symptoms using the CDI without a diagnostic interview. Finally, it is possible that many of the children
with severe depression symptoms were absent from
school during the study period, which may have attenuated the association.
In conclusion, we have demonstrated that one out of
ten schoolchildren in Kuwait has depression symptoms
and that 25(OH)D is not associated with having depression symptoms in our setting. It is important to have
sufficient vitamin D levels during adolescence for several other health benefits.
Abbreviations
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